MEDICAL ONCOLOGY, cilt.24, sa.1, ss.39-43, 2007 (SCI-Expanded)
Background: Activity of tamoxifen as a salvage therapy in patients with advanced epithelial ovarian cancer was evaluated by a number of studies. In this study, we evaluated efficacy of tamoxifen in our patients with platinum-resistant epithelial ovarian carcinoma.